-
Population pharmacokinetics of ramosetron.
Journal of pharmacokinetics and pharmacodynamics 20160201
-
Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.
Expert opinion on drug metabolism & toxicology 20130401
-
A meta-analysis of prevention of postoperative nausea and vomiting: randomised controlled trials by Fujii et al. compared with other authors.
Anaesthesia 20121001
-
Retraction record rocks community.
Nature 20120920
-
Inhibitory effect of ramosetron on corticotropin releasing factor- and soybean oil-induced delays in gastric emptying in rats.
Journal of gastroenterology and hepatology 20120901
-
Comparison of the antiemetic effect of ramosetron and combined ramosetron and midazolam in children: a double-blind, randomised clinical trial.
European journal of anaesthesiology 20120401
-
Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20111201
-
Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20111201
-
Intravenous, oral, and the combination of intravenous and oral ramosetron for the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, controlled trial.
Clinical therapeutics 20110901
-
Retraction Notice: Current review of ramosetron in the prevention of postoperative nausea and vomiting.
Current drug safety 20110401
-
Prevention of nausea and vomiting during termination of pregnancy.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20101001
-
Prophylactic control of post-operative nausea and vomiting using ondansetron and ramosetron after cardiac surgery.
Acta anaesthesiologica Scandinavica 20100901
-
Matching groups for studying postoperative nausea and vomiting: should we care?
Surgical endoscopy 20100701
-
Comparison of ramosetron and ondansetron for control of post-operative nausea and vomiting following laparoscopic cholecystectomy.
Indian journal of medical sciences 20100601
-
Comparison of the prophylactic anti-emetic efficacy of ramosetron and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement.
Anaesthesia 20100501
-
Ramosetron versus ondansetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy.
Surgical endoscopy 20100401
-
A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting.
Japanese journal of clinical oncology 20100401
-
Serotonin 5-HT3 receptor antagonist for treatment of severe diabetic diarrhea.
Diabetes care 20100301
-
Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists.
International journal of clinical oncology 20091201
-
Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery.
British journal of anaesthesia 20091001
-
[Pharmacological and clinical profile of ramosetron hydrochloride (Irribow), a novel therapeutic agent for irritable bowel syndrome with diarrhea].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20090501
-
Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer.
Japanese journal of clinical oncology 20090201
-
The effect of oral and IV ramosetron on postoperative nausea and vomiting in patients undergoing gynecological laparoscopy with total intravenous anesthesia.
Journal of anesthesia 20090101
-
Preoperatively administered ramosetron oral disintegrating tablets for preventing nausea and vomiting associated with patient-controlled analgesia in breast cancer patients.
European journal of anaesthesiology 20080901
-
Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron.
Spine 20080801
-
The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects.
European journal of clinical pharmacology 20080701
-
Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats.
European journal of pharmacology 20080610
-
The effect of paroxetine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects.
European journal of clinical pharmacology 20080601
-
[Clinical evaluation of antiemetic effects of 5-hydroxytryptamine receptor type 3 (5HT3 receptor) antagonists based on changes in eating condition in cancer patients receiving chemotherapy].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080401
-
Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.
Journal of pharmacological sciences 20080201
-
A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome.
Scandinavian journal of gastroenterology 20080101
-
A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome.
Digestion 20080101
-
Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
European journal of pharmacology 20071114
-
Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.
Journal of pharmacological sciences 20070701
-
[Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 20070301
-
Pharmacological profile of ramosetron, a novel therapeutic agent for IBS.
Inflammopharmacology 20070201
-
Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study.
Chemotherapy 20070101
-
Effects of serotonin-3 receptor antagonists on cytochrome P450 activities in human liver microsomes.
Biological & pharmaceutical bulletin 20060901
-
[Comparison of ramosetron and azasetron for prevention of acute and delayed cisplatin-induced emesis in lung cancer patients].
Gan to kagaku ryoho. Cancer & chemotherapy 20060501
-
Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
Japanese journal of clinical oncology 20051201
-
[A randomized crossover study of ramosetron plus dexamethasone for the prevention of nausea and vomiting induced by chemotherapy including cisplatin-comparison of ramosetron combined with 8 mg and 12 mg of dexamethasone].
Gan to kagaku ryoho. Cancer & chemotherapy 20051201
-
Exogenous melatonin delays gastric emptying rate in rats: role of CCK2 and 5-HT3 receptors.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20051201
-
Comparative clinical study of the anti-emetic effects of oral ramosetron and injected granisetron in patients with malignant glioma undergoing ACNU chemotherapy.
Neurologia medico-chirurgica 20050601
-
[Effect of steroid on antiemetic for side effect of anticancer chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 20050301
-
A randomized clinical trial of a single dose of ramosetron for the prevention of vomiting after strabismus surgery in children: a dose-ranging study.
Archives of ophthalmology (Chicago, Ill. : 1960) 20050101
-
Inhibitory effect of glucocorticoids on human-cloned 5-hydroxytryptamine3A receptor expressed in xenopus oocytes.
Anesthesiology 20040901
-
Benefits and risks of granisetron versus ramosetron for nausea and vomiting after breast surgery: a randomized, double-blinded, placebo-controlled trial.
American journal of therapeutics 20040101
-
A randomized, double-blind, placebo-controlled trial of ramosetron for preventing nausea and vomiting during termination of pregnancy.
International journal of obstetric anesthesia 20040101
-
[Preventive effects of ramosetron and granisetron in prevention of gastrointestinal reaction associated with chemotherapeutic agents: a comparative study].
Zhonghua yi xue za zhi 20031210
-
A double-blind, crossover, randomized comparison of granisetron and ramosetron for the prevention of acute and delayed cisplatin-induced emesis in patients with gastrointestinal cancer: is patient preference a better primary endpoint?
Chemotherapy 20031201
-
Randomized, double-blind, placebo-controlled, dosed-finding study of the antiemetic effects and tolerability of ramosetron in adults undergoing middle ear surgery.
Clinical therapeutics 20031201
-
Results of a prospective, randomized, double-blind, placebo-controlled, dose-ranging trial to determine the effective dose of ramosetron for the prevention of vomiting after tonsillectomy in children.
Clinical therapeutics 20031201
-
[Evaluation of QOL with orally disintegrating antiemetic tablets in outpatient chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 20031001
-
[Effects of Nasea on prevention of gastrointestinal side effects caused by chemotherapeutic drugs].
Zhonghua yi xue za zhi 20030710
-
Prophylactic antiemetic efficacy of granisetron or ramosetron in patients undergoing thyroidectomy.
Asian journal of surgery 20021001
-
Clinical comparison of the selective serotonin3 antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea and anorexia.
Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20020901
-
The effect of the selective 5-HT(3) receptor agonist on ferret gut motility.
Life sciences 20020802
-
Contribution of P-glycoprotein to efflux of ramosetron, a 5-HT3 receptor antagonist, across the blood-brain barrier.
The Journal of pharmacy and pharmacology 20020801
-
Double-blind, placebo-controlled, dose-ranging study of ramosetron for the prevention of nausea and vomiting after thyroidectomy.
Clinical therapeutics 20020701
-
Comparison of granisetron and ramosetron for the prevention of nausea and vomiting after thyroidectomy.
Clinical therapeutics 20020501
-
Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting.
Drugs of today (Barcelona, Spain : 1998) 20020201
-
Effects of ondansetron, granisetron, ramosetron, and azasetron on human neutrophil functions.
Gynecologic and obstetric investigation 20020101
-
Clinical evaluation of Ramosetron injections in the treatment of cisplatin-induced nausea and vomiting.
The Journal of international medical research 20020101
-
Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron.
The Journal of international medical research 20020101
-
Prophylaxis of nausea and vomiting after laparoscopic cholecystectomy with ramosetron: randomised controlled trial.
The European journal of surgery = Acta chirurgica 20020101
-
A novel 5-HT3 receptor agonist, YM-31636, increases gastrointestinal motility without increasing abdominal pain.
European journal of pharmacology 20011109
-
[Analysis of 5-HT3 receptor antagonist, ramosetron hydrochloride, based on receptor occupancy considering its active metabolite].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20011101
-
[Evaluation of efficacy of ramosetron orally disintegrating tablets and patient preference as to the dosage form in gynecological cancer chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 20010801
-
Ramosetron compared with granisetron for the prevention of vomiting following strabismus surgery in children.
The British journal of ophthalmology 20010601
-
Ramosetron for the management of chemotherapy-induced gastrointestinal events in patients with hematological malignancies.
Methods and findings in experimental and clinical pharmacology 20010501
-
Prevention of vomiting after tonsillectomy in children: granisetron versus ramosetron.
The Laryngoscope 20010201
-
Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery.
Anesthesia and analgesia 20000201
-
Effect of the 5-hydroxytryptamine3 (5-HT3)-receptor antagonist KB-R6933 on experimental diarrhea models.
Japanese journal of pharmacology 19990501
